Published 1 month ago • loading... • Updated 30 days ago

FDA Approves Mirikizumab for Crohn Disease

Summary by ajmc.com

The FDA granted approval to Eli Lilly and Company’s mirikizumab-mrkz (Omvoh) for Crohn disease, expanding its treatment reach to now include the full spectrum of inflammatory bowel disease.

This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

4 Articles

All

Left

Center

Right

ajmc.com

FDA Approves Mirikizumab for Crohn Disease

The FDA granted approval to Eli Lilly and Company’s mirikizumab-mrkz (Omvoh) for Crohn disease, expanding its treatment reach to now include the full spectrum of inflammatory bowel disease.

30 days ago

Read Full Article

pharmaceutical-technology.com

FDA approves drug application for Lupin’s heart failure therapy

The FDA has granted approval for the ANDA of Lupin’s Sacubitril and Valsartan Tablets for heart failure patients.

1 month ago

Read Full Article

Lupin

Lupin Receives U.S. FDA Approval for Sacubitril and Valsartan Tablets

1 month ago

Read Full Article

aboutlawsuits.com

Court Asked To Establish Valsartan Settlement Fund and Appoint Administrator

The U.S. District Judge presiding over all federal Valsartan lawsuits has been asked to approve the creation of a qualified settlement fund, as well as appoint a settlement administrator and custodian for funds that will be paid by certain generic manufacturers of the recalled hypertension drug, which has been linked to the development of cancers among former users. There are currently more than 1,200 product liability lawsuits being pursued aga…

1 month ago

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year